386 related articles for article (PubMed ID: 16756189)
1. Clinical trials in India: balancing economic opportunity with the public health context.
Dandona L
Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
[No Abstract] [Full Text] [Related]
2. A new colonialism?--Conducting clinical trials in India.
Nundy S; Gulhati CM
N Engl J Med; 2005 Apr; 352(16):1633-6. PubMed ID: 15843665
[No Abstract] [Full Text] [Related]
3. Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
[No Abstract] [Full Text] [Related]
4. Clinical trials in India sponsored by the pharmaceutical industry: a proposal for reforms.
Pai M; Colford JM
Natl Med J India; 2002; 15(2):93-6. PubMed ID: 12044124
[No Abstract] [Full Text] [Related]
5. Patients, physicians, and clinical trials: the other side of the coins.
Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
[No Abstract] [Full Text] [Related]
6. Piercing the veil of corporate secrecy about clinical trials.
Lemmens T
Hastings Cent Rep; 2004; 34(5):14-8. PubMed ID: 15553393
[No Abstract] [Full Text] [Related]
7. [Economic benefit and ethical challenges].
Riska O
Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1990. PubMed ID: 18800394
[No Abstract] [Full Text] [Related]
8. Trading on traditional medicines.
Basu P
Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
[No Abstract] [Full Text] [Related]
9. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
Ferris LE
CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
[No Abstract] [Full Text] [Related]
10. Leaders worry that U.S. is losing edge on cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
[No Abstract] [Full Text] [Related]
11. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
ten Cate JW; Büller HR
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials: the pitfalls of interpretation.
Lokhandwalla Y; Dalvi B
Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700
[No Abstract] [Full Text] [Related]
13. India's drug tests.
Padma TV
Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
[No Abstract] [Full Text] [Related]
14. [Clinical drug research in Denmark--as effective, harmless and cheap as possible].
Højgaard L
Ugeskr Laeger; 1994 Feb; 156(6):784-6. PubMed ID: 8016979
[No Abstract] [Full Text] [Related]
15. [Dishonesty in clinical trials is expensive for the society 3].
Waldorff S
Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
[No Abstract] [Full Text] [Related]
16. [Dishonesty in clinical trials is expensive for the society 2].
Lund BA; Nordby G
Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556
[No Abstract] [Full Text] [Related]
17. [Dishonesty in clinical trials is expensive for the society 1].
Heslet L; Nielsen JD; Schierbeck J
Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555
[No Abstract] [Full Text] [Related]
18. Clinical trials in India.
Maiti R; M R
Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
[TBL] [Abstract][Full Text] [Related]
19. India emerges as new drug proving ground.
Slater J
Wall St J (East Ed); 2004 Feb; ():B1, B7. PubMed ID: 15290808
[No Abstract] [Full Text] [Related]
20. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
